Senior VP of clinical research, deputy chief clinical officer of the neurology business group, Eisai Ltd
Understanding Irsenontrine’s Role Among Neurodegenerative Disorders: Michael Irizarry, MD, PhD
The senior VP of clinical research at Eisai discussed findings from a phase 2 study assessing irsenontrine in patients with dementia with Lewy bodies and Parkinson disease dementia. [WATCH TIME: 4 minutes]
Emerging Tools for Early Detection of Alzheimer Disease
The field of Alzheimer disease has entered a new era of earlier detection, creating an opportunity to redefine treatment and the clinical care of patients.
Michael Irizarry, MD, MPH: Mechanism of Lorcaserin in Dravet Syndrome
The vice president of Clinical Research at Eisai detailed why lorcaserin’s formula made it suitable for treating patients with Dravet syndrome.
2 Clarke Drive Cranbury, NJ 08512